BioMS Gaining Traction

BioMS, an Edmonton, Alberta based biotech company working on a treatment for Multiple Sclerosis has seen its stock double from its lows of October 30th when the stock traded at $1.95. 

BioMS (T-MS), is nearing completion of phase 3 trials that it has been conducting in North America and Europe. The company was a spin off out of the University of Alberta’s Research department many years ago.

We have been following this story for the greater part of 5 years and the author does own a position in the company. 

The stock really started to move as Bloomberg published an article on the company last week. I have attached a link below to the article.

http://www.bloomberg.com/apps/news?pid=newsarchive&sid=aWth2ME0_ZNs

While I am optimistic on the longer term prospects of the company, it is important to note that there has been downward pressure on the stock each time it trades close to $4.00. The company has raised money several times in the past and each time has issued warrants exercisable at $4.00.

Once the overhang on the $4.00 price has been traded out, the stock could see higher pricing in the future.  If you are looking for a Canadian biotech stock to own and there arent many, this is one you may want to consider.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: